Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens

Due to limited new antibiotics, polymyxins are increasingly used to treat multidrug-resistant (MDR) Gram-negative bacteria, in particular carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Unfortunately, polymyxin monotherapy has led to the emergence of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Microbiol
Glavni autori: Tran, Thien B., Wang, Jiping, Doi, Yohei, Velkov, Tony, Bergen, Phillip J., Li, Jian
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Microbiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906568/
https://ncbi.nlm.nih.gov/pubmed/29706941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.00721
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items